Advancing rheumatology through public relations
Search results for: hip OA
Trillions of SNPs Versus a Glass of Grappa
Will personalized medicine make us healthier or just contribute to information overload?
Promoting Arthritis Research to Congress and Others
The ACR works to promote clinical and basic research in arthritis and musculoskeletal disease through a variety of channels, including advocacy, working directly with the National Institutes of Health (NIH), and through the work of the ACR Research and Education Foundation.
RheumPAC: Advance Rheumatology on Capital Hill
One way to succeed in our mission of advancing rheumatology is to increase the ACR’s presence on Capitol Hill through grassroots and direct lobbying. However, for the rheumatology subspecialty to be most effective we must use all tools available to us, including RheumPAC, the ACR’s nonpartisan political action committee. RheumPAC demonstrates to members of Congress that the rheumatology subspecialty is committed to political action, educating policy makers, and improving healthcare for our patients.
Gabriel to Chair Healthcare Reform Panel
Former ACR president assigned key role in transforming nation’s healthcare system
Opioids More Dangerous than other Analgesics for Elderly
Safety events vary among different opioids
A View of Industry from the Inside
Rheumatologists with pharmaceutical careers discuss the path that led them to industry and the work they do
Drug UPDATES
Information on New Approvals and Medication Safety
He Taught Us to Always Go Deeper
Eng Tan, MD, promotes translation from bench to bedside
Rheum with a View
Panush’s perspectives on selections from the literature
- « Previous Page
- 1
- …
- 287
- 288
- 289
- 290
- 291
- …
- 325
- Next Page »